B
Biobytes utilizes artificial intelligence to predict sarcopenia, a condition characterized by the loss of muscle mass and strength in aging populations. By providing early detection and risk assessment, the solution enables healthcare providers to implement timely interventions and improve patient outcomes.
Updated 19 months ago
Funding
$440K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
KV
Funding rounds are not available yet.
Founders
Product
Features
- Biobytes utilizes artificial intelligence to predict sarcopenia, a condition characterized by the loss of muscle mass and strength in aging populations. By providing early detection and risk assessment, the solution enables healthcare providers to implement timely interventions and improve patient outcomes.